Summit Therapeutics Total Shareholders Equity 2011-2026 | SMMT

Annual Total Shareholders Equity Summit Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
659 M	389 M	77.7 M	127 M	83.3 M	79.5 M	78.9 M	32.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
659 M	32.2 M	191 M

Quarterly Total Shareholders Equity Summit Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
192 M	259 M	344 M	389 M	438 M	195 M	44.2 M	77.7 M	99.4 M	120 M	133 M	127 M	133 M	51.3 M	64.4 M	83.3 M	102 M	119 M	64.4 M	79.5 M	79.5 M	79.5 M	79.5 M	78.9 M	77.2 M	43.6 M	51.2 M	32.2 M	-	-	-	-4.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
438 M	-4.4 M	125 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	16.9 M	-	10.36 %	$ 9.8 M	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Avenue Therapeutics ATXI	1.83 M	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	4.16 M	-	-16.42 %	$ 249 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	195 M	-	-	$ 546 M	USA
Allakos ALLK	169 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	9.93 M	-	-5.38 %	$ 6.06 M	USA
Atreca BCEL	78.4 M	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	84.5 M	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	3.36 M	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	286 M	-	-	$ 3.74 B	USA
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Bellerophon Therapeutics BLPH	2.53 M	-	-74.18 %	$ 955 K	USA
Chimerix CMRX	193 M	-	-	$ 756 M	USA
AbbVie ABBV	-3.27 B	$ 208.7	-0.07 %	$ 369 B	USA
Calithera Biosciences CALA	8.38 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	20.9 M	-	-3.03 %	$ 260 M	USA
AbCellera Biologics ABCL	967 M	$ 3.52	-0.14 %	$ 1.05 B	Canada